You Position: Home > Paper
Cerebral Venous Sinus Thrombosis as the First Manifestation of JAK2V617F-positive Essential Thrombocythemia
( views:20, downloads:4 )
- Author:
- No author available
- Journal Title:
- Chinese Medical Journal
- Issue:
- 6
- DOI:
- 10.4103/0366-6999.226903
- Key Word:
- No keyword available
Abstract： To the Editor:Essential thrombocythemia (ET) complicated by cerebral venous sinus thrombosis (CVST) is exceptionally rare.Hitherto,few studies have mentioned the role of Janus kinase 2V617F (JAK2V617F) mutation in ET patients who developed CVST;thus,the strategy and long-term outcomes are yet rarely reported.The present study documented four cases,wherein CVST was the first manifestation ofJAK2V617F-positive ET.
- [1].Development and validation of an International Prognostic Score of thrombosis in World Health Organization-essential thrombocythemia (IPSET-thrombosis)[J].2012,120(26).
- [2]Arber, Daniel A.,Orazi, Attilio,Hasserjian, Robert,etc.The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia[J].2016,127(20).
- [3]Zoi K,Giannouli S,Zoi C,etc.Is JAK2 V617F mutation more than a diagnostic index? A meta-analysis of clinical outcomes in essential thrombocythemia.[J].2009,33(1).
- [4]Tefferi, Ayalew,Barbui, Tiziano.Polycythemia vera and essential thrombocythemia: 2017 update on diagnosis, risk-stratification, and management[J].2017,92(1).
- [5]Pagani C,Caberlon S,Lussana F.Association of V617F Jak2 mutation with the risk of thrombosis among patients with essential thrombocythaemia or idiopathic myelofibrosis: a systematic review.[J].2009,124(4).
- [6]Ferro J. M.,Bousser M.‐G.,Canh?o P.,etc.European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis - endorsed by the European Academy of Neurology[J].2017,24(10).
- [7]R. Shirzad,F. Rahim,A. Saki Malehi,etc.Estimation of diagnosis and prognosis in ET by assessment of CALR and JAK2 V617F mutations and laboratory findings: a meta-analysis[J].2017,19(7).